NOVA LTD. (NVMI): what the price assumes

In the published model solve dated 2026-Q2, anchored at $402.80, NOVA LTD. (NVMI) is priced for today's economics sustained for ~17.4 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/NVMI

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 7: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 12.5% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.6 years.

Reconcile: at the x-ray's 9.3% required return this reads ~10.1 years; the models below use their own rates.

How unusual the bet is: high

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=18)

Solvency

Bullet Takeaways

• Nova makes the measurement and inspection tools chipmakers use to control their manufacturing processes, and it posted record Q1 2026 revenue of $235.3 million with GAAP earnings of $2.04 per share, riding demand for advanced DRAM and chip packaging.
• The defining risk is the valuation: no family of standard valuation method reaches the price, which trades at a steep multiple that requires Nova to keep growing for roughly two decades to justify it.
• Watch the memory and packaging cycle: advanced DRAM is about two-thirds of Nova's memory business, and management guided second-quarter revenue of $222 million to $232 million, with high-bandwidth memory, gate-all-around chips, and advanced packaging as the named growth drivers.

Bull Case

The number that defines Nova's bull case is its operating margin, which runs around 27% on a trailing basis and pushed higher in the latest quarter. That margin is the proof of a structural advantage: Nova sells specialized metrology and inspection equipment, the tools that measure and verify chips during manufacturing, and that niche carries pricing power because the tools are deeply embedded in customers' production lines and switching them out risks yield. A company earning a high-20s operating margin in a hardware business is not competing on price; it is competing on indispensability.

The demand backdrop has shifted in Nova's favor in a way that is structural rather than merely cyclical. Q1 2026 set revenue records at $235.3 million, up 10% year over year, with GAAP net income of $69.3 million, or $2.04 per diluted share. The drivers are the most durable themes in semiconductors: advanced DRAM, which now accounts for roughly two-thirds of Nova's memory business, plus high-bandwidth memory, gate-all-around transistors, and advanced packaging. Each of these adds manufacturing steps and complexity, and more complexity means more measurement, which is exactly what Nova sells. Record sales of its Metrion platform, driven by repeat purchases from a leading memory customer, show the tools winning designed-in positions rather than one-off orders.

The balance sheet gives the company room to invest through any air pocket. Net debt is minimal at about $195 million, roughly a quarter of a year's operating income, interest coverage runs well over a hundred times, and the share count has grown only about 2% a year. Management guided second-quarter revenue of $222 million to $232 million and pointed to continued growth into 2026 and 2027 on the same packaging and memory drivers. The bull case is that Nova sits at the intersection of every rising semiconductor complexity trend, with the margins and balance sheet to compound through the cycle.

Bear Case

The hardest fact for a buyer to reconcile is that no standard way of valuing Nova can reach its price. Asset value, earnings power, peer multiples, and even forward growth all land below the current level, several of them far below: the earnings-power methods sit around a tenth of the price, the asset-based methods well under, and the peer multiples around 40% under. When every lens points the same direction, the stock is not a case of one cautious model lagging a story; it is priced beyond what any standard frame supports. The qualitative version of that is simpler: an excellent company can still be an expensive stock, and Nova is being priced for an outcome that has to be both large and durable.

The inversion shows how much durability is required. To justify the price, the company must keep compounding for roughly two decades, an unusually long runway for any business and an especially demanding one in semiconductors, where capital-equipment demand moves in cycles. Wafer-fab-equipment spending rises and falls with chipmakers' capital budgets, and those budgets are notoriously lumpy. The current strength in advanced DRAM and packaging is real, but it is also a favorable point in the cycle, and a memory downturn or a pause in customer capital spending would compress the growth the price assumes. The stock fell on the day of the strong Q1 print, which tells you the market is already alert to the valuation risk even when the operating news is good.

There is also a concentration-and-geopolitics dimension the price does not obviously reflect. Nova's revenue leans on a relatively small set of leading memory and logic customers, so a single customer's capital pullback carries outsized weight, and the company's Israel base adds a layer of geopolitical and regional risk that a U.S.-domiciled peer does not carry. Solvency is not the concern here, with net debt under a third of a year's operating income and coverage above a hundred times, so this is not a balance-sheet bear. It is a valuation-and-durability bear: the price requires the best case to play out for a very long time, and there is no cheap method underneath to catch a disappointment.

Valuation

Nova trades at a price that the standard valuation methods cannot reach. Asset value, earnings power, peer multiples, and forward growth all land below the current level, with the earnings-power family sitting roughly a tenth of the price and the others well under. The pattern is unambiguous: this is a bet beyond what any standard frame supports, which means the price is underwriting an outcome materially larger and longer-lived than what trailing fundamentals show.

The inversion makes the bet concrete. At today's price, the company must sustain growth for roughly two decades against a trailing operating margin around 27% that the price implicitly assumes holds or improves. That is a long runway to ask of any business, and a demanding one for a semiconductor-equipment maker whose end demand follows the wafer-fab-equipment cycle. The growth-based methods come closest to the price because they credit future expansion, but even they sit below it. The right comparison set is the semiconductor process-control and scientific-instruments cohort, where high margins and embedded-tool positions command premium multiples, but Nova's premium sits at the top even of that group.

Solvency is a strength rather than a constraint, which is why the valuation question dominates. Net debt of about $195 million is roughly a quarter of a year's operating income, interest coverage exceeds a hundred times, and the share count has grown only about 2% a year, so the balance sheet can fund investment through any downturn without strain. That removes distress from the downside entirely and leaves the central question as durability: the price assumes Nova compounds at the intersection of advanced memory and packaging for many years. If those drivers persist, the premium is the market correctly pricing a structural winner; if the cycle turns or customer spending pauses, there is no valuation floor beneath the price to soften the move.

Catalysts

Nova's Q1 2026 report in mid-May was a record on the operating lines but met a cool market reaction. Revenue reached $235.3 million, up 6% sequentially and 10% year over year, with GAAP net income of $69.3 million, or $2.04 per diluted share. Despite the record, the stock fell on the print, a sign that expectations and the valuation had already run ahead of the numbers. Management guided second-quarter revenue of $222 million to $232 million, broadly in line with consensus.

The business drivers point to continued momentum. Advanced DRAM applications made up roughly two-thirds of Nova's memory business, and the company cited record sales of its Metrion platform on repeat orders from a leading memory customer, alongside growing adoption of its WMC platform in advanced packaging. Management framed high-bandwidth memory demand, gate-all-around transistor adoption, and advanced packaging as structural growth drivers expected to contribute a rising share of revenue into 2026 and 2027, which is the through-line for the next several quarters of results.

Analyst sentiment reset higher after the quarter. Several firms lifted price targets, with the central target moving up to roughly $598 from about $497 and a number of estimates landing in the $590 to $640 range, citing stronger revenue and margin expectations and the packaging and memory momentum. The events most likely to move the stock from here are the trajectory of memory and advanced-packaging demand, any change in major customers' capital-spending plans, and the broader wafer-fab-equipment cycle, since each feeds directly into the long growth runway the price requires.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• CAMT (CAMTEK LTD)
• (no filing in the citation store)
• KLAC (KLA CORPORATION)
• FY2025 10-K: …In addition, Commerce has imposed export licensing requirements on China-based customers that are military end users or engaged in military end uses. It also requires our customers to obtain an export license when they use certain semiconductor capital equipment based on U.S. technology to manufacture products…
• FY2025 10-K: …development and manufacturing processes to enhance productivity, improve yields and reduce waste. To remain competitive, we use significant financial resources to offer a broad range of products, to maintain customer service and support centers worldwide, and to invest significantly in product R&D. In each of our…
• ONTO (ONTO INNOVATION INC.)
• FY2025 10-K: …we have. In automated systems for the semiconductor industry, our principal competitors are KLA Corporation ("KLA") and Nova Ltd. (formerly Nova Measuring Instruments Ltd.) ("Nova") for thin film and critical dimension OCD metrology. Our principal competitors for advanced packaging inspection are KLA and Camtek Ltd.…
• FY2025 10-K: …competitors in each product area to continue to improve the design and performance of their products and to introduce new products with competitive prices and performance characteristics. These product introductions would likely require us to decrease the prices of our systems and increase the level of discounts that…
• COHU (COHU INC)
• FY2025 10-K: …and prudent situations such as, for example, when the resulting tax benefit exceeds the costs involved to obtain such tax benefit, and the success of prevailing upon pursuing the competent authority is more-likely-than-not achievable. 11. Segment and Geographic Information We applied the provisions of ASC 280, which…
• FY2025 10-K: …increased 12.7%, year-over-year, to $453.0 million. Revenue from our capital equipment products is primarily driven by customers' capital expenditures and operating budgets, which can fluctuate significantly based on variations in their business conditions. These expenditures depend on current and anticipated market…
• TER (TERADYNE, INC.)
• FY2025 10-K: Table of Contents Sales to customers outside the United States were 89%, 87%, and 84%, respectively, of our consolidated revenues in 2025, 2024 and 2023. Sales are attributed to geographic areas based on the location of the customer site. See also "Item 1A: Risk Factors" and Note V: "Segment, Geographic, and…
• FY2025 10-K: …the current segment structure and presentation requirements. The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services inclusive of storage and system level test products. The Robotics segment includes operations related to the…
• KEYS (KEYSIGHT TECHNOLOGIES, INC.)
• FY2025 10-K: …technologies, software-defined vehicles, industrial IoT, digital health, and fab capacity. Revenue for EISG in 2024 decreased 12 percent compared to 2023. Acquisitions had a favorable impact of 7 percentage points on the year-over-year revenue change, while foreign currency movements had an unfavorable impact of 1…
• FY2025 10-K: …market represented approximately 67 percent of total CSG revenue in 2025 and increased 10 percent compared to 2024. Revenue increased across all regions. T he year-over-year increase was primarily driven by R&D investments in terabit solutions and expanding 400G/800G transceiver manufacturing capacity to meet rising…
• MKSI (MKS INC)
• FY2025 10-K: …for 2025, 2024 and 2023, respectively. In any reporting period, these customers may contribute an even larger percentage of our consolidated net revenues. The loss of any of these customers or a significant reduction in orders by these customers, including due to economic, market or competitive conditions, regulatory…
• FY2025 10-K: …harmed. We operate in highly competitive markets characterized by rapid technological advances, frequent product introductions and enhancements, changing customer requirements, evolving industry standards, substantial capital investment and increasing price pressure. Our success depends upon our ability to…
• COHR (COHERENT CORP.)
• FY2025 10-K: …and display capital equipment verticals in the industrial end market. Gross margin. Gross margin for the year ended June 30, 2024 was $1,456 million, or 31%, of total revenues, compared to $1,618 million, or 31% of total revenues, for fiscal 2023, a slight decrease of 43 basis points. During fiscal 2023, the Company…
• FY2025 10-K: …revenue increased $40 million year-over-year reflecting higher volumes of annealing lasers in our display capital equipment market partially offset by continued soft demand in precision manufacturing. Materials decreased $63 million year-over-year, primarily due to softness in the Silicon Carbide business. Gross…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.